Task: Answer the MCQ question.
Question: What is the human ether-à-go-go related gene (hERG) inhibition at 1uM of a drug with the SMILES CCCCN1C(=O)C(NC(=O)c2cccnc2)(C(F)(F)F)C2=C1CC(C)(C)CC2=O?
Constraint: You must return none, one or more options from a, b, c, or d without using any additional words.
Options:
a 7.924
b 22.212
c 3.613
d 0.707
Answer: c. 3.613\%.
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: What is the {herg_central_at_1uM__names__noun} of a {#compound|drug!} with the {SMILES__description} {SMILES#}?
Constraint: You must return none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{herg_central_at_1uM%SMILES%}
Answer: {%multiple_choice_result}. {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCCCN1C(=O)C(NC(=O)c2cccnc2)(C(F)(F)F)C2=C1CC(C)(C)CC2=O
CCCCN1C(=O)C(NC(=O)c2cccnc2)(C(F)(F)F)C2=C1CC(C)(C)CC2=O
N-[1-butyl-6,6-dimethyl-2,4-dioxo-3-(trifluoromethyl)-5,7-dihydroindol-3-yl]pyridine-3-carboxamide